By 2032, the Organ Preservation Market will be worth US$ 455 million, expanding at a compound annual growth rate of 6.4%. Organ preservation is the act of conserving healthy donor organs so they can be transplanted into the bodies of recipients. Static cold storage (SCS), which stops toxic metabolites from destroying healthy tissue, helps to sustain normal organ function following transplantation.
Organ Preservation Market Overview:
The act of keeping healthy organs after they have been removed from donors' bodies is known as organ preservation. Without causing much harm, organs are removed from the donor's body, transported, and then transplanted into the body of the recipient. The results of this study indicate that the adoption of organ preservation is directly impacted by the increased prevalence of chronic illnesses.
Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14363
Organ preservation for transplantation has a strong influence on donor organ quality, which has a direct impact on a patient’s morbidity and survival rates following transplantation. One of the major factors driving the growth of the organ preservation solutions market is the increasing prevalence of chronic illnesses, as well as the world’s growing elderly population.
Because of the increasing number of organ failures caused by diabetes, cardiovascular diseases (CVDs), obesity, and other serious medical problems, static cold storage organ preservation treatments are becoming more common. Innovative and sophisticated organ preservation strategies, such as NMP, act as a growth-inducing agent.
In clinical and experimental research, such strategies help to reduce the risk of reperfusion damage after transplantation and improve static cold storage organ preservation results. Furthermore, an increasing number of government and non-government regulations and activities to encourage organ donation are positively impacting the growth of the organ preservation solutions market.
The growing number of people who volunteer to donate their organs for transplantation and research is also propelling the market forward. Other factors, such as increased R&D and significant developments in the global organ preservation market, are expected to significantly contribute to market expansion.
- A preservation injury occurs when the liver no longer functions. A liver transplant, also known as a hepatic transplant, has the potential to save someone’s life. A liver transplant may also be recommended by a doctor to a patient who has reached the end stage of liver disease.
- Individuals who received a liver transplant had an 89% chance of survival after one year, according to an article published in the American Journal of Transplantation. The growing need for organ transplantation is propelling the global organ preservation market across the board.
- According to the American Transplant Foundation, approximately 114,000 people in the United States are currently on the waiting list for a life-saving organ transplant. Every day, on average, 20 people die due to a lack of available organs for transplantation.
The global organ preservation marketis dominated by companies such as Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut (Netherlands).
Key Market Segments Covered in the Study:
- University of Wisconsin Solution (UW Solution)
- Custodial HTK
- Other Solutions
- Static Cold Storage
- Hypothermia Machine Perfusion
- Normothermic Machine Perfusion
By Organ Type:
By End User:
- Organ Transplant Centres
- Speciality Clinics